Showing 1,528 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Martin Shkreli walks back on pledge to lower price of HIV drug Daraprim

Editor's pick
The Guardian
26 November 2015
Hepatitis C treatment

Pricing Pressures: How the Business of Medicine Affects the Price of Therapy

Editor's pick
Healio HCV Next
16 November 2015
Hepatitis C treatment

U.S. FDA approves new indications for Harvoni®, Gilead’s once-daily single tablet regimen for chronic hepatitis C

Editor's pick
Gilled press release
13 November 2015
Pharmaceutical industry

High Cost of HIV Meds, Other Drugs Should Be Top Presidential Concern, Most Americans Say

Editor's pick
The Body
11 November 2015
PrEP

'Significant Victory' as Gilead Expands Co-Pay Assistance for Truvada as PrEP

Editor's pick
Poz
6 November 2015
New & experimental HIV treatments

FDA approves new treatment for HIV

Editor's pick
FDA press release
6 November 2015
Pharmaceutical industry

Why are HIV meds so expensive, and what can we do about it?

Editor's pick
BETA blog
29 October 2015
Pharmaceutical industry

GlaxoSmithKline beats sales forecasts thanks to HIV drugs boost

Editor's pick
The Guardian
28 October 2015
Pharmaceutical industry

Gilead hepatitis C drug sales trend flattens, shares dip

Editor's pick
Reuters
28 October 2015
Access to healthcare

South Africa should override patent on key HIV medicine after widespread stock out problem

Editor's pick
MSF
27 October 2015
Pharmaceutical industry

WikiLeaks publication of complete, final TPP Intellectual Property text confirms pact would raise costs, put medicines out of reach

Editor's pick
Public Citizen
12 October 2015
PrEP

PrEP: The Pathway to Global Access

Editor's pick
TAG
7 October 2015
Access to healthcare

Trade deal is big win for big pharma, health rights advocates say

Editor's pick
Al Jazeera
6 October 2015
Pharmaceutical industry

AIDS Activists Protest Price Gauging of Meds by Hedge Funds

Editor's pick
Poz magazine news
3 October 2015
Pharmaceutical industry

European CHMP adopts positive opinion for Gilead’s single tablet regimen Genvoya® (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide) for the treatment of HIV

Editor's pick
EATG
1 October 2015
Pharmaceutical industry

Martin Shkreli Is Just a Tiny Part of a Huge Problem

Editor's pick
The Atlantic
28 September 2015
Pharmaceutical industry

The banal evil of drug pricing

Editor's pick
Ground Up
25 September 2015
Pharmaceutical industry

Why the 5000% price hike for pyrimethamine in the US is relevant in the UK

Editor's pick
HIV i-Base
24 September 2015
Pharmaceutical industry

How an obscure drug’s 4,000% price increase might finally spur action on soaring health-care costs

Editor's pick
Washington Post
22 September 2015
Pharmaceutical industry

Nonprofit Gets Back Drug and Reverses 18-Fold Increase in Price

Editor's pick
Bloomberg
22 September 2015
Pharmaceutical industry

Hedge funder Martin Shkreli buys rights to drug used by HIV patients and raises price from $13.50 to $750 per pill

Editor's pick
The Independent
22 September 2015
Pharmaceutical industry

Big Price Increase for TB Drug Is Rescinded

Editor's pick
New York Times
22 September 2015
Pharmaceutical industry

GSK takes on Gilead with new two-drug HIV treatments

Editor's pick
Reuters
22 September 2015
TB treatment

WHO Sounds Alarm Over Big Indian Supplier Of Tuberculosis Drugs

Editor's pick
Medical Daily
15 September 2015